Jan Terje Andersen (Jan T Andersen)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 26

Top Topics

Monoclonal Antibody

Top Venues

Nature communications

Communications biology

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Habib Bashour, Eva Smorodina, Matteo Pariset, Jahn Zhong, Rahmad Akbar, Maria Chernigovskaya, Khang Lê Quý, Igor Snapkow, Puneet Rawat, Konrad Krawczyk, Geir Kjetil F Sandve, José Gutiérrez Marcos, Daniel Nakhaee-Zadeh Gutierrez, Jan Terje Andersen, Victor Greiff
Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability. Communications biology 7 (1) (2024)
Habib Bashour, Eva Smorodina, Matteo Pariset, Jahn Zhong, Rahmad Akbar, Maria Chernigovskaya, Khang Lê Quý, Igor Snapkow, Puneet Rawat, Konrad Krawczyk, Geir Kjetil F Sandve, José Gutiérrez Marcos, Daniel Nakhaee-Zadeh Gutierrez, Jan Terje Andersen, Victor Greiff
Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability. Communications biology 7 (1) (2024)
Habib Bashour, Eva Smorodina, Matteo Pariset, Jahn Zhong, Rahmad Akbar, Maria Chernigovskaya, Khang Lê Quý, Igor Snapkow, Puneet Rawat, Konrad Krawczyk, Geir Kjetil F Sandve, José Gutiérrez Marcos, Daniel Nakhaee-Zadeh Gutierrez, Jan Terje Andersen, Victor Greiff
Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability. Communications biology 7 (1) (2024)
Stian Foss, Siri Aastedatter Sakya, Leire Aguinagalde, Marta Lustig, Jutamas Shaughnessy, Ana Rita Cruz, Lisette Scheepmaker, Line Mathiesen, Fulgencio Ruso-Julve, Aina Karen Anthi, Torleif Tollefsrud Gjølberg, Simone Mester, Malin Bern, Mitchell Evers, Diane B Bratlie, Terje E Michaelsen, Tilman Schlothauer, Devin Sok, Jayanta Bhattacharya, Jeanette Leusen, Thomas Valerius, Sanjay Ram, Suzan H M Rooijakkers, Inger Sandlie, Jan Terje Andersen
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria. Nature communications 15 (1) (2024)
Stian Foss, Siri Aastedatter Sakya, Leire Aguinagalde, Marta Lustig, Jutamas Shaughnessy, Ana Rita Cruz, Lisette Scheepmaker, Line Mathiesen, Fulgencio Ruso-Julve, Aina Karen Anthi, Torleif Tollefsrud Gjølberg, Simone Mester, Malin Bern, Mitchell Evers, Diane B Bratlie, Terje E Michaelsen, Tilman Schlothauer, Devin Sok, Jayanta Bhattacharya, Jeanette Leusen, Thomas Valerius, Sanjay Ram, Suzan H M Rooijakkers, Inger Sandlie, Jan Terje Andersen
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria. Nature communications 15 (1) (2024)
Stian Foss, Siri Aastedatter Sakya, Leire Aguinagalde, Marta Lustig, Jutamas Shaughnessy, Ana Rita Cruz, Lisette Scheepmaker, Line Mathiesen, Fulgencio Ruso-Julve, Aina Karen Anthi, Torleif Tollefsrud Gjølberg, Simone Mester, Malin Bern, Mitchell Evers, Diane B Bratlie, Terje E Michaelsen, Tilman Schlothauer, Devin Sok, Jayanta Bhattacharya, Jeanette Leusen, Thomas Valerius, Sanjay Ram, Suzan H M Rooijakkers, Inger Sandlie, Jan Terje Andersen
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria. Nature communications 15 (1) (2024)
Stian Foss, Siri Aastedatter Sakya, Leire Aguinagalde, Marta Lustig, Jutamas Shaughnessy, Ana Rita Cruz, Lisette Scheepmaker, Line Mathiesen, Fulgencio Ruso-Julve, Aina Karen Anthi, Torleif Tollefsrud Gjølberg, Simone Mester, Malin Bern, Mitchell Evers, Diane B Bratlie, Terje E Michaelsen, Tilman Schlothauer, Devin Sok, Jayanta Bhattacharya, Jeanette Leusen, Thomas Valerius, Sanjay Ram, Suzan H M Rooijakkers, Inger Sandlie, Jan Terje Andersen
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria. Nature communications 15 (1) (2024)
Sopisa Benjakul, Aina Karen Anthi, Anette Kolderup, Marina Vaysburd, Heidrun Elisabeth Lode, Donna L Mallery, Even Fossum, Elisabeth Lea Vikse, Anna Albecka, Aleksandr Ianevski, Denis E Kainov, Karine Flem Karlsen, Siri Aastedatter Sakya, Mari Nyquist-Andersen, Torleif Tollefsrud Gjølberg, Morten C Moe, Magnar Bjørås, Inger Sandlie, Leo C James, Jan Terje Andersen
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery. PNAS nexus 2 (12) (2023)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Aamir S Mukadam, Lauren V C Miller, Annabel E Smith, Marina Vaysburd, Siri Aastedatter Sakya, Sophie A I Sanford, Sophie Keeling, Benjamin J Tuck, Taxiarchis Katsinelos, Christopher Green, Lise R Skov, Sanne Simone Kaalund, Stian Foss, Keith Mayes, Kevin O'Connell, Mark Wing, Claire Knox, Jessica Banbury, Edward Avezov, James Benedict Rowe, Michel Goedert, Jan Terje Andersen, Leo C James, William A McEwan
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models. Science (New York, N.Y.) 379 (6639) (2023)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Aamir S Mukadam, Lauren V C Miller, Annabel E Smith, Marina Vaysburd, Siri Aastedatter Sakya, Sophie A I Sanford, Sophie Keeling, Benjamin J Tuck, Taxiarchis Katsinelos, Christopher Green, Lise R Skov, Sanne Simone Kaalund, Stian Foss, Keith Mayes, Kevin O'Connell, Mark Wing, Claire Knox, Jessica Banbury, Edward Avezov, James Benedict Rowe, Michel Goedert, Jan Terje Andersen, Leo C James, William A McEwan
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models. Science (New York, N.Y.) 379 (6639) (2023)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Torleif Tollefsrud Gjølberg, Jonas Aakre Wik, Hanna Johannessen, Stig Krüger, Nicola Bassi, Panagiotis F Christopoulos, Malin Bern, Stian Foss, Goran Petrovski, Morten Carstens Moe, Guttorm Haraldsen, Johanna Hol Fosse, Bjørn Steen Skålhegg, Jan Terje Andersen, Eirik Sundlisæter
Antibody blockade of Jagged1 attenuates choroidal neovascularization. Nature communications 14 (1) (2023)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Rahmad Akbar, Philippe A Robert, Cédric R Weber, Michael Widrich, Robert Frank, Milena Pavlović, Lonneke Scheffer, Maria Chernigovskaya, Igor Snapkov, Andrei Slabodkin, Brij Bhushan Mehta, Enkelejda Miho, Fridtjof Lund-Johansen, Jan Terje Andersen, Sepp Hochreiter, Ingrid Hobæk Haff, Guenter Klambauer, Geir Kjetil F Sandve, Victor Greiff
In silico proof of principle of machine learning-based antibody design at unconstrained scale. mAbs 14 (1) (2022)
Torleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, Stian Foss, Algirdas Grevys, Lene Støkken Høydahl, Øystein Kalsnes Jørstad, Tilman Schlothauer, Inger Sandlie, Morten Carstens Moe, Jan Terje Andersen
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life. Communications biology 5 (1) (2022)
Trude Victoria Mørtberg, Huiying Zhi, Gestur Vidarsson, Stian Foss, Suzanne Lissenberg-Thunnissen, Dana L E Vergoossen, Terje E Michaelsen, Bjørn Skogen, Tor B Stuge, Jan Terje Andersen, Peter J Newman, Maria Therese Ahlén
Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal Antibody. ImmunoHorizons 6 (1) (2022)
Jack Wade, Charlotte Rimbault, Hanif Ali, Line Ledsgaard, Esperanza Rivera-de-Torre, Maher Abou Hachem, Kim Boddum, Nadia Mirza, Markus-Frederik Bohn, Siri A Sakya, Fulgencio Ruso-Julve, Jan Terje Andersen, Andreas Hougaard Laustsen
Generation of Multivalent Nanobody-Based Proteins with Improved Neutralization of Long α-Neurotoxins from Elapid Snakes. Bioconjugate chemistry 33 (8) (2022)
Rahmad Akbar, Habib Bashour, Puneet Rawat, Philippe A Robert, Eva Smorodina, Tudor-Stefan Cotet, Karine Flem-Karlsen, Robert Frank, Brij Bhushan Mehta, Mai Ha Vu, Talip Zengin, José Gutiérrez Marcos, Fridtjof Lund-Johansen, Jan Terje Andersen, Victor Greiff
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies. mAbs 14 (1) (2022)
Stian Foss, Alexandra Jonsson, Maria Bottermann, Ruth Elizabeth Watkinson, Heidrun E Lode, Martin B McAdam, Terje E Michaelsen, Inger Sandlie, Leo C James, Jan Terje Andersen
Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge. Science immunology 7 (70) (2022)
Silvia Lombardi, Kristin Hovden Aaen, Jeannette Nilsen, Mattia Ferrarese, Torleif T Gjølberg, Francesco Bernardi, Mirko Pinotti, Jan Terje Andersen, Alessio Branchini
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity. British journal of haematology 194 (2) (2021)
Andreas Barrat-Due, Inge Christoffer Olsen, Katerina Nezvalova-Henriksen, Trine Kåsine, Fridtjof Lund-Johansen, Hedda Hoel, Aleksander Rygh Holten, Anders Aune Tveita, Alexander Mathiessen, Mette Haugli, Ragnhild Eiken, Anders Benjamin Kildal, Aase Berg, Asgeir Johannessen, Lars Heggelund, Tuva Børresdatter Dahl, Karoline Hansen Skåra, Pawel Mielnik, Lan Ai Kieu Le, Lars Thoresen, Gernot Ernst, Dag Arne Lihaug Hoff, Hilde Skudal, Bård Reiakvam Kittang, Roy Bjørkholt Olsen, Birgitte Tholin, Carl Magnus Ystrøm, Nina Vibeche Skei, Trung Tran, Susanne Gjeruldsen Dudman, Jan Terje Andersen, Raisa Hannula, Olav Dalgard, Ane-Kristine Finbråten, Kristian Tonby, Bjorn Blomberg, Saad Aballi, Cathrine Fladeby, Anne Katrine Steffensen, Fredrik Müller, Anne Margarita Dyrhol-Riise, Marius Trøseid, Pål Aukrust, null null
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial. Annals of internal medicine 174 (9) (2021)
Malin Bern, Jeannette Nilsen, Mattia Ferrarese, Kine M K Sand, Torleif T Gjølberg, Heidrun E Lode, Robert J Davidson, Rodney M Camire, Espen S Bækkevold, Stian Foss, Algirdas Grevys, Bjørn Dalhus, John Wilson, Lene Støkken Høydahl, Gregory J Christianson, Derry C Roopenian, Tilman Schlothauer, Terje E Michaelsen, Morten Carstens Moe, Silvia Lombardi, Mirko Pinotti, Inger Sandlie, Alessio Branchini, Jan Terje Andersen
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics. Science translational medicine 12 (565) (2021)
Kristin Hovden Aaen, Aina Karen Anthi, Inger Sandlie, Jeannette Nilsen, Simone Mester, Jan Terje Andersen
The neonatal Fc receptor in mucosal immune regulation. Scandinavian journal of immunology 93 (2) (2021)
Corinna Lau, Martin Berner McAdam, Grethe Bergseth, Algirdas Grevys, Jack Ansgar Bruun, Judith Krey Ludviksen, Hilde Fure, Terje Espevik, Anders Moen, Jan Terje Andersen, Tom Eirik Mollnes
NHDL, a recombinant VL/VH hybrid antibody control for IgG2/4 antibodies. mAbs 12 (1) (2021)